Literature DB >> 33547350

Molecular characterization of atherosclerosis in HIV positive persons.

Adam Cornwell1, Rohith Palli2,3, Meera V Singh4, Lauren Benoodt3, Alicia Tyrell5,6, Jun-Ichi Abe7,8, Giovanni Schifitto5,6, Sanjay B Maggirwar9, Juilee Thakar10,11,12.   

Abstract

People living with HIV are at higher risk of atherosclerosis (AS). The pathogenesis of this risk is not fully understood. To assess the regulatory networks involved in AS we sequenced mRNA of the peripheral blood mononuclear cells (PBMCs) and measured cytokine and chemokine levels in the plasma of 13 persons living with HIV and 12 matched HIV-negative persons with and without AS. microRNAs (miRNAs) are known to play a role in HIV infection and may modulate gene regulation to drive AS. Hence, we further assessed miRNA expression in PBMCs of a subset of 12 HIV+ people with and without atherosclerosis. We identified 12 miRNAs differentially expressed between HIV+ AS+ and HIV+ , and validated 5 of those by RT-qPCR. While a few of these miRNAs have been implicated in HIV and atherosclerosis, others are novel. Integrating miRNA measurements with mRNA, we identified 27 target genes including SLC4A7, a critical sodium and bicarbonate transporter, that are potentially dysregulated during atherosclerosis. Additionally, we uncovered that levels of plasma cytokines were associated with transcription factor activity and miRNA expression in PBMCs. For example, BACH2 activity was associated with IL-1β, IL-15, and MIP-1α. IP10 and TNFα levels were associated with miR-124-3p. Finally, integration of all data types into a single network revealed increased importance of miRNAs in network regulation of the HIV+ group in contrast with increased importance of cytokines in the HIV+ AS+ group.

Entities:  

Year:  2021        PMID: 33547350      PMCID: PMC7865026          DOI: 10.1038/s41598-021-82429-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  108 in total

1.  MicroRNA-210, MicroRNA-331, and MicroRNA-7 Are Differentially Regulated in Treated HIV-1-Infected Individuals and Are Associated With Markers of Systemic Inflammation.

Authors:  Vibe Ballegaard; Ulrik Ralfkiaer; Karin K Pedersen; Malene Hove; Simon Koplev; Peter Brændstrup; Lars P Ryder; Hans O Madsen; Jan Gerstoft; Kirsten Grønbæk; Susanne D Nielsen
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

2.  Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions.

Authors:  R G Gerrity; H K Naito
Journal:  Artery       Date:  1980

3.  MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection.

Authors:  Jun Huang; Lingyan Zhu; Chao Qiu; Xuan Xu; Linxia Zhang; Xiangqing Ding; Qibin Liao; Jianqing Xu; Xiaoyan Zhang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

4.  Optimized logic rules reveal interferon-γ-induced modes regulated by histone deacetylases and protein tyrosine phosphatases.

Authors:  Daniel Van Twisk; Shawn P Murphy; Juilee Thakar
Journal:  Immunology       Date:  2017-02-09       Impact factor: 7.397

Review 5.  Human immune system variation.

Authors:  Petter Brodin; Mark M Davis
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

6.  Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Authors:  Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa El-Sadr; Stephan De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

Review 7.  MicroRNAs and human retroviruses.

Authors:  Laurent Houzet; Kuan-Teh Jeang
Journal:  Biochim Biophys Acta       Date:  2011-05-24

8.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Identification of miR-34a-target interactions by a combined network based and experimental approach.

Authors:  Martin Hart; Stefanie Rheinheimer; Petra Leidinger; Christina Backes; Jennifer Menegatti; Tobias Fehlmann; Friedrich Grässer; Andreas Keller; Eckart Meese
Journal:  Oncotarget       Date:  2016-06-07

Review 10.  Impact of miRNA in Atherosclerosis.

Authors:  Yao Lu; Tanuja Thavarajah; Wenduo Gu; Jingjing Cai; Qingbo Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

View more
  2 in total

Review 1.  Atherosclerosis in HIV Patients: What Do We Know so Far?

Authors:  Anastasia V Poznyak; Evgeny E Bezsonov; Evgeny E Borisov; Andrey V Grechko; Andrey G Kartuesov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

2.  Executable models of immune signaling pathways in HIV-associated atherosclerosis.

Authors:  Mukta G Palshikar; Rohith Palli; Alicia Tyrell; Sanjay Maggirwar; Giovanni Schifitto; Meera V Singh; Juilee Thakar
Journal:  NPJ Syst Biol Appl       Date:  2022-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.